Dialysis News and Research

Latest Dialysis News and Research

FMCNA introduces newly branded Frenova Renal Research business

Fresenius Medical Care North America, the world's largest provider of dialysis services, today introduced its newly branded Frenova Renal Research business, the only Phase I-IV drug and device clinical development partner dedicated exclusively to renal research.

26 Mar 2014

AM-Pharma reports positive results from recAP Phase I trial for Acute Kidney Injury

AM-Pharma B.V., a biopharmaceutical company focused on the development of recAP (recombinant human Alkaline Phosphatase) for inflammatory indications, announces the results of its Phase I trial with both single and multiple ascending doses, which demonstrate that recAP is safe and well tolerated at all doses.

26 Mar 2014

Renal Ventures Management publishes first cookbook of kidney friendly recipes for renal patients

In recognition of Kidney Health Awareness Month, Renal Ventures Management, LLC (RVM), a leading provider of dialysis services for patients suffering from chronic kidney failure, has published its first cookbook of kidney friendly recipes for it renal patients and their families.

25 Mar 2014

Otsuka obtains regulatory approval in Japan for pharmacological treatment of ADPKD

Otsuka Pharmaceutical Co., Ltd. today announced it has become the first company in the world to obtain regulatory approval for a pharmacological treatment of autosomal dominant polycystic kidney disease (ADPKD). Samsca (generic name: tolvaptan) has been approved in Japan in 7.5-mg and 15-mg tablet forms for extended use for the additional indication of ADPKD. Also, the new dosage form of 30-mg Samsca tablets has received approval for the indication of ADPKD.

24 Mar 2014

Sparton completes all-cash transaction to acquire Aubrey Group

Sparton Corporation announces that it completed an all-cash transaction to acquire Aubrey Group, Inc., an $8 million revenue business, on March 17, 2014. Aubrey will continue to service its current and future customers out of its Irvine, CA location.

18 Mar 2014

Scientists discover that natural product in grapefruit can prevent kidney cysts

Scientists at Royal Holloway, University of London, have discovered that a natural product found in grapefruit can prevent kidney cysts from forming.

13 Mar 2014

DaVita to host Google+ Hangout on Air to global kidney disease awareness on World Kidney Day

DaVita, a division of DaVita HealthCare Partners Inc. and a leading provider of kidney care services, will host a Google+ Hangout on Air dedicated to global kidney disease awareness on World Kidney Day.

11 Mar 2014

CSI's new Diamondback Peripheral 60cm systems receive FDA clearance for PAD treatment

Cardiovascular Systems, Inc., announced today it has received FDA clearance of its new Diamondback 360 60cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD).

10 Mar 2014

Fibrotech successfully completes Phase Ia trial of anti-fibrotic compound FT011

Fibrotech, an Australian biopharmaceutical company developing a new class of drugs to prevent a massive health burden associated with fibrosis, today announced that its lead anti-fibrotic compound FT011 has successfully completed a Phase Ia trial in healthy volunteers demonstrating safety and tolerability up to doses of 1000mg.

10 Mar 2014

Incyte Corporation publishes results of Phase III trial of ruxolitinib in patients with polycythemia vera

Incyte Corporation (Nasdaq: INCY) today announced that a pivotal Phase III trial of ruxolitinib compared to best available therapy in patients with polycythemia vera who are resistant to or intolerant of hydroxyurea has met its primary endpoint of achieving phlebotomy independence and reducing spleen size by 35 percent or more.

7 Mar 2014

Cell-cycle arrest biomarkers validated for acute kidney injury

Saeed A. Jortani, Ph.D., associate clinical professor in the University of Louisville's Department of Pathology and Laboratory Medicine, headed up one of three labs in the United States involved in determining two new markers for acute kidney injury (AKI). The research group's paper, "Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical Adjudication," was posted online Feb. 25 by the American Journal of Respiratory and Critical Care Medicine.

5 Mar 2014

Protamine antidote can be effective in reversing low-molecular-weight heparin

Low-molecular-weight heparin is commonly used in surgeries to prevent dangerous blood clots. But when patients experience the other extreme - uncontrolled bleeding - in response to low-molecular-weight heparin, there is no antidote.

4 Mar 2014

Experts recommend several steps to improve care for prisoners

The very premise of prison invites members of society to think of the people there as walled-off and removed. But more than 95 percent of prisoners will return to the community, often carrying significant health burdens and associated costs with them. In an article in the March issue of the journal Health Affairs, several experts who participated in a scientific workshop convened by the National Research Council and the Institute of Medicine recommend several steps and ideas consistent with health reform to improve care for prisoners while they are incarcerated and after they return to society.

4 Mar 2014

New research uncovers abnormal molecular signaling pathways for kidney failure

Prevention and reversal of chronic kidney disease is an urgent public health need. The disease affects 1 in 10 Americans, is debilitating and deadly, and existing drugs, at best, offer only mild delay in progression to end-stage kidney failure.

4 Mar 2014

Tooth extraction before heart surgery carries risks

Dental extraction before cardiac surgery may not be as benign a procedure as some clinicians might think, with review findings showing that it is associated with major adverse outcomes.

28 Feb 2014

NxStage Medical revenue increases 7% to $69.4 million in fourth quarter 2013

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record financial results for the three and twelve months ended December 31, 2013, that include revenue slightly above its recent guidance.

27 Feb 2014

Patients with dental extractions before cardiac surgery still at risk for poor outcomes

To pull or not to pull? That is a common question when patients have the potentially dangerous combination of abscessed or infected teeth and the need for heart surgery.

27 Feb 2014

Computerized safety checklist shows threefold drop in rates of serious type of hospital-acquired infection

A computerized safety checklist that automatically pulls information from patients' electronic medical records was associated with a threefold drop in rates of one serious type of hospital-acquired infection, according to a study by researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford.

24 Feb 2014

Italian Society of Nephrology and Springer join forces to promote research in renal diseases

Beginning in 2014, Springer will publish the Journal of Nephrology, the official publication of the Italian Society of Nephrology. The new agreement will enable the journal to expand and strengthen its mission to stimulate advancements in medicine, focusing on nephrology, dialysis and renal transplantation.

20 Feb 2014

Researchers detail how psoralen blocks signaling pathway of HER2-positive cancers

A common compound known to fight lymphoma and skin conditions actually has a second method of action that makes it particularly deadly against certain aggressive breast tumors, researchers at Duke Medicine report.

18 Feb 2014

Dialysis News and Research

Latest Dialysis News and Research

FMCNA introduces newly branded Frenova Renal Research business

AM-Pharma reports positive results from recAP Phase I trial for Acute Kidney Injury

Renal Ventures Management publishes first cookbook of kidney friendly recipes for renal patients

Otsuka obtains regulatory approval in Japan for pharmacological treatment of ADPKD

Sparton completes all-cash transaction to acquire Aubrey Group

Scientists discover that natural product in grapefruit can prevent kidney cysts

DaVita to host Google+ Hangout on Air to global kidney disease awareness on World Kidney Day

CSI's new Diamondback Peripheral 60cm systems receive FDA clearance for PAD treatment

Fibrotech successfully completes Phase Ia trial of anti-fibrotic compound FT011

Incyte Corporation publishes results of Phase III trial of ruxolitinib in patients with polycythemia vera

Cell-cycle arrest biomarkers validated for acute kidney injury

Protamine antidote can be effective in reversing low-molecular-weight heparin

Experts recommend several steps to improve care for prisoners

New research uncovers abnormal molecular signaling pathways for kidney failure

Tooth extraction before heart surgery carries risks

NxStage Medical revenue increases 7% to $69.4 million in fourth quarter 2013

Patients with dental extractions before cardiac surgery still at risk for poor outcomes

Computerized safety checklist shows threefold drop in rates of serious type of hospital-acquired infection

Italian Society of Nephrology and Springer join forces to promote research in renal diseases

Researchers detail how psoralen blocks signaling pathway of HER2-positive cancers

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in